These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22937955)

  • 1. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.
    Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J
    Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
    Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
    Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
    Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
    Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis.
    Pardanani A; Phyliky RL; Li CY; Tefferi A
    Mayo Clin Proc; 2003 Mar; 78(3):301-6. PubMed ID: 12630583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma].
    Szturz P; Adam Z; Rehák Z; Koukalová R; Kodet R; Nebeský T; Neubauer J; Moulis M; Smardová L; Mayer J
    Vnitr Lek; 2010 Nov; 56(11):1177-93. PubMed ID: 21250497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.
    Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z
    Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cladribine activity in adult langerhans-cell histiocytosis.
    Saven A; Burian C
    Blood; 1999 Jun; 93(12):4125-30. PubMed ID: 10361109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy.
    Lazor R; Etienne-Mastroianni B; Khouatra C; Tazi A; Cottin V; Cordier JF
    Thorax; 2009 Mar; 64(3):274-5. PubMed ID: 19252036
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
    Yao X; Ying H; Weihong Z; Qing S; Xintian L
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
    Baumann M; Cerny T; Sommacal A; Koeberle D
    Hematol Oncol; 2012 Jun; 30(2):101-4. PubMed ID: 21732400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
    Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ
    Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis, a case of Letterer Siwe disease.
    Pant C; Madonia P; Bahna SL; Bass PF; Jeroudi M
    J La State Med Soc; 2009; 161(4):211-2. PubMed ID: 19785312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
    Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A
    Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.